Related Experiment Video

Updated: Feb 24, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

MicroRNA-132 suppresses cell proliferation in human breast cancer by directly targeting FOXA1

Dan Wang1, Jin Ren2, Hui Ren3

  • 1Department of Breast Surgery.

Acta Pharmacologica Sinica
|August 18, 2017
PubMed

Insights

MicroRNA 132 (miR-132) suppresses breast cancer cell proliferation by inhibiting FOXA1. This finding suggests miR-132 and FOXA1 as potential therapeutic targets for breast cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs (miRNAs) play a crucial role in cancer development.
  • miR-132 is frequently downregulated in breast cancer tissues.
  • FOXA1 is a transcription factor implicated in various cancers.

Purpose of the Study:

  • To investigate the functional role of miR-132 in breast cancer.
  • To identify and validate FOXA1 as a direct target of miR-132.
  • To explore the therapeutic potential of targeting the miR-132/FOXA1 axis in breast cancer.

Main Methods:

  • Bioinformatic analysis to predict miR-132 targets.
  • Dual luciferase reporter assays to confirm direct interaction between miR-132 and FOXA1.
  • Western blotting and cell proliferation assays to assess the functional impact of miR-132 and FOXA1 modulation in breast cancer cell lines (MDA-MB-468 and SK-BR3).

Main Results:

  • FOXA1 expression was significantly upregulated and inversely correlated with miR-132 levels in human breast cancer tissues.
  • miR-132 directly targeted and inhibited FOXA1 expression at the post-transcriptional level.
  • Overexpression of miR-132 suppressed breast cancer cell proliferation, while its knockdown promoted proliferation; these effects were mediated through FOXA1.

Conclusions:

  • miR-132 functions as a tumor suppressor in breast cancer by inhibiting FOXA1.
  • The miR-132/FOXA1 pathway represents a novel mechanism regulating breast cancer cell growth.
  • miR-132 and FOXA1 hold promise as potential diagnostic biomarkers and therapeutic targets for breast cancer.

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K